TLX
Telix Pharms
Stock
Stock
ISIN: AU000000TLX2
Ticker: TLX
AU000000TLX2
TLX
Price
Price
CHART BY
Frequently asked questions
What is Telix Pharms's market capitalization?
The market capitalization of Telix Pharms is 3.48B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the free float of Telix Pharms's shares?
The free float of Telix Pharms is 275.99M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 3.48B
- Free Float
- 275.99M
Pricing
- 1D span
- $10.12$10.42
- 52W span
- $5.936$12.35
Information
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- AU000000TLX2
- Primary Ticker
- TLX
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet